<DOC>
	<DOCNO>NCT01193127</DOCNO>
	<brief_summary>The purpose study determine whether use OMS302 ( study drug ) individual undergo Cataract Extraction Lens Replacement ( CELR ) surgery safe effective maintain adequately dilate pupil surgery reduce post-operative symptom discomfort ( eye pain irritation ) .</brief_summary>
	<brief_title>Safety Efficacy OMS302 Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement ( CELR )</brief_title>
	<detailed_description />
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Mydriatics</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Competent willing voluntarily provide informed consent 18 year age older In good general health need undergo cataract extraction lens replacement surgery one eye , topical anesthesia Other inclusion criterion evaluate investigator No allergy medication and/or active ingredient study medication No medication activity active ingredient OMS302 define time interval prior surgery No significant eye injury , eye condition general medical condition likely interfere evaluation study medication Other exclusion criterion evaluate investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>